HAE
HAEMONETICS CORP
NYSE · Healthcare · Medical - Instruments & Supplies · US
$118.41
−0.27%Oct 19, 2026, 20:15 UTC
The U.S. Food and Drug Administration approved HAEMONETICS CORP’s PerQseal Elite vascular closure system for large-bore arterial procedures in the United States.
Source:Oct 8, 2026, 16:12 UTC
HAEMONETICS CORP shares rose more than 13% to $115.20 on Thursday.
Oct 8, 2026, 14:09 UTC
CSL Limited plans to use HAEMONETICS CORP' plasma collection equipment across all its existing U.S. centers, expanding an earlier supply agreement.
Sep 30, 2026, 20:05 UTC
Haemonetics Corporation announced it will publish its second quarter fiscal year 2027 financial results on November 5, 2026.
Source:Sep 15, 2026, 12:30 UTC
Haemonetics Corporation acquired Vivasure Medical Limited, with Orchestra BioMed receiving a $6.1 million milestone payment on September 14, 2026 as part of the deal.
Source:Aug 18, 2026, 23:49 UTC
Haemonetics Corp shares surged 15.9% to $104.65 on August 18, 2026.
Source:Aug 6, 2026, 10:00 UTC
Haemonetics Corporation announced that its financial results for the first quarter of fiscal year 2027, which ended June 27, 2026, are available on its Investor Relations website.